Sodium-Glucose Co-Transporter 2 Inhibitors and the Potential for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Mellitus

Cardiovascular Risk ◽

Risk Reduction ◽

Cardiovascular Risk Reduction

Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-017-6750-1 ◽

2017 ◽

Vol 31 (4) ◽

pp. 459-470 ◽

Cited By ~ 3

Author(s):

Scott L. Purga ◽

Mandeep Sidhu ◽

Michael Farkouh ◽

Joshua Schulman-Marcus

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Reduction ◽

Cardiovascular Risk Reduction

Sodium-Glucose Co-transporter 2 Inhibitor: A Perspective on Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus

Hypertension Journal ◽

10.5005/jp-journals-10043-0046 ◽

2016 ◽

Vol 2 (3) ◽

pp. 139-144

Author(s):

Gary E Sander ◽

Camilo Fernandez ◽

Philip J Kadowitz ◽

Thomas D Giles

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Reduction ◽

Cardiovascular Risk Reduction

Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus

Diabetes Therapy ◽

10.1007/s13300-017-0329-5 ◽

2017 ◽

Vol 9 (1) ◽

pp. 27-36 ◽

Cited By ~ 3

Author(s):

Marc Evans ◽

Plamen Kozlovski ◽

Päivi M. Paldánius ◽

James E. Foley ◽

Vaishali Bhosekar ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Reduction ◽

Young Patients ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-of-the-Art Review

Mayo Clinic Proceedings ◽

10.1016/j.mayocp.2018.07.018 ◽

2018 ◽

Vol 93 (11) ◽

pp. 1629-1647 ◽

Cited By ~ 14

Author(s):

Salvatore Carbone ◽

Dave L. Dixon ◽

Leo F. Buckley ◽

Antonio Abbate

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Reduction ◽

State Of The Art ◽

Glucose Lowering

Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?

Current Cardiology Reports ◽

10.1007/s11886-018-1051-2 ◽

2018 ◽

Vol 20 (11) ◽

Cited By ~ 11

Author(s):

Yixing Li ◽

Paul D. Rosenblit

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Reduction ◽

Class Effect ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Weight Management for Type 2 Diabetes Mellitus: Global Cardiovascular Risk Reduction

The American Journal of Cardiology ◽

10.1016/j.amjcard.2006.11.007 ◽

2007 ◽

Vol 99 (4) ◽

pp. 68-79 ◽

Cited By ~ 49

Author(s):

Michelle Lee ◽

Louis J. Aronne

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Reduction ◽

Weight Management ◽

Global Cardiovascular Risk

Assessing The Consistency Of Absolute Cardiovascular Risk Prediction And Relative Risk Reduction In Type-2 Diabetes Mellitus

Value in Health ◽

10.1016/j.jval.2013.03.826 ◽

2013 ◽

Vol 16 (3) ◽

pp. A165

Author(s):

P. McEwan ◽

M. Lamotte ◽

D. Grant ◽

J.L. Palmer ◽

A. Lloyd ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Relative Risk ◽

Risk Reduction ◽

Relative Risk Reduction ◽

Cardiovascular Risk Prediction ◽

Absolute Cardiovascular Risk

Use of a Single Target Blood Pressure Level in Type 2 Diabetes Mellitus for All Cardiovascular Risk Reduction

Archives of Internal Medicine ◽

10.1001/archinternmed.2012.4020 ◽

2012 ◽

Vol 172 (17) ◽

pp. 1304 ◽

Cited By ~ 5

Author(s):

Pantelis A. Sarafidis ◽

George L. Bakris

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Blood Pressure Level ◽

Pressure Level ◽

Single Target

Association of plasma testosterone concentration with cardiovascular risk factors in young Chinese men of type 2 diabetes mellitus

Endocrine Abstracts ◽

10.1530/endoabs.32.p393 ◽

2013 ◽

Author(s):

Xin Li ◽

Miao Yang ◽

Yuwen Wu ◽

SuXin Sun

Keyword(s):

Diabetes Mellitus ◽

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Plasma Testosterone ◽

Chinese Men ◽

Testosterone Concentration

2259-PUB: Aging, Systolic Hypertension, Obesity, and Hyperuricemia Increase the Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus in Northwest China

Diabetes ◽

10.2337/db20-2259-pub ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2259-PUB

Author(s):

QINGBIN ZHAO

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Systolic Hypertension ◽

Northwest China